VelThor's standards for sourcing, oversight, tolerability, and the framing of compounded medications — explained in plain language.
VelThor works with licensed pharmacy partners — including 503A and 503B compounding pharmacies where applicable. We require sterility and potency documentation, and we audit our partners on a recurring basis. We don't list pharmacy names publicly to protect supply-chain stability, but partner credentials are reviewed during onboarding and shared with regulators on request.
Every prescription is signed off by a licensed provider — by name, with individual accountability. The model is asynchronous (the provider reviews your assessment rather than meeting you live in most cases) but every recommendation is human-reviewed, not algorithm-driven. Your provider can request more information, decline to prescribe, or recommend a different pathway entirely.
GLP-1 medications, including semaglutide and tirzepatide, have a documented safety profile that requires individual evaluation by a licensed provider. Common side effects can include nausea, fatigue, constipation, or injection-site reactions; serious risks are rare but require prompt clinical attention. Treatment may be appropriate for some adults and not others, which is why every VelThor pathway begins with a structured assessment and provider review. For ESL protocols, tolerability is reviewed individually and protocols are positioned as supportive rather than curative. Direct access to the clinical team is included in every plan.
Compounded GLP-1 medications are prepared by a licensed compounding pharmacy and dispensed only after individual provider review. Compounded formulations are not FDA-approved drugs; they are individualized preparations dispensed pursuant to a valid prescription. Our position is that compounded options can be appropriate for individual patients when prescribed and reviewed by a licensed provider — and inappropriate when treated as substitutes for individual clinical judgment. That standard applies across every pathway.
Begin a structured assessment to see how those standards apply to your individual plan.
